

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | omega-hydroxylase P450 pathway (GO:0097267) | 8.31159035 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.63601959 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 7.63601959 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.28241060 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 7.28241060 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 6.92293595 |
| 7 | tryptophan catabolic process (GO:0006569) | 6.27711199 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 6.27711199 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 6.27711199 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.19503116 |
| 11 | oxidative demethylation (GO:0070989) | 6.17448829 |
| 12 | bile acid biosynthetic process (GO:0006699) | 6.10751590 |
| 13 | kynurenine metabolic process (GO:0070189) | 6.09560133 |
| 14 | drug metabolic process (GO:0017144) | 6.07108828 |
| 15 | tryptophan metabolic process (GO:0006568) | 5.89924359 |
| 16 | urea metabolic process (GO:0019627) | 5.80118708 |
| 17 | urea cycle (GO:0000050) | 5.80118708 |
| 18 | glyoxylate metabolic process (GO:0046487) | 5.77734639 |
| 19 | complement activation, alternative pathway (GO:0006957) | 5.61987350 |
| 20 | negative regulation of fibrinolysis (GO:0051918) | 5.59740422 |
| 21 | alpha-linolenic acid metabolic process (GO:0036109) | 5.51390120 |
| 22 | regulation of protein activation cascade (GO:2000257) | 5.50961075 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 5.47542597 |
| 24 | phenylpropanoid metabolic process (GO:0009698) | 5.46246569 |
| 25 | regulation of fibrinolysis (GO:0051917) | 5.42578876 |
| 26 | cysteine metabolic process (GO:0006534) | 5.38773603 |
| 27 | sulfur amino acid catabolic process (GO:0000098) | 5.38224402 |
| 28 | protein carboxylation (GO:0018214) | 5.37099216 |
| 29 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.37099216 |
| 30 | ethanol metabolic process (GO:0006067) | 5.33499126 |
| 31 | nitrogen cycle metabolic process (GO:0071941) | 5.33493664 |
| 32 | acute-phase response (GO:0006953) | 5.19451504 |
| 33 | regulation of humoral immune response (GO:0002920) | 5.17965187 |
| 34 | negative regulation of protein activation cascade (GO:2000258) | 5.17866005 |
| 35 | regulation of complement activation (GO:0030449) | 5.17525122 |
| 36 | bile acid metabolic process (GO:0008206) | 5.16911256 |
| 37 | opsonization (GO:0008228) | 5.15665874 |
| 38 | serine family amino acid catabolic process (GO:0009071) | 5.14082896 |
| 39 | regulation of plasminogen activation (GO:0010755) | 5.08657164 |
| 40 | aromatic amino acid family metabolic process (GO:0009072) | 5.02000943 |
| 41 | homocysteine metabolic process (GO:0050667) | 4.95028014 |
| 42 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.89595986 |
| 43 | regulation of triglyceride catabolic process (GO:0010896) | 4.87085440 |
| 44 | tyrosine metabolic process (GO:0006570) | 4.84956922 |
| 45 | regulation of cholesterol esterification (GO:0010872) | 4.76674276 |
| 46 | reverse cholesterol transport (GO:0043691) | 4.76090880 |
| 47 | protein-lipid complex remodeling (GO:0034368) | 4.70948295 |
| 48 | macromolecular complex remodeling (GO:0034367) | 4.70948295 |
| 49 | plasma lipoprotein particle remodeling (GO:0034369) | 4.70948295 |
| 50 | negative regulation of hemostasis (GO:1900047) | 4.70695621 |
| 51 | negative regulation of blood coagulation (GO:0030195) | 4.70695621 |
| 52 | alpha-amino acid catabolic process (GO:1901606) | 4.68776683 |
| 53 | lysine metabolic process (GO:0006553) | 4.64146256 |
| 54 | lysine catabolic process (GO:0006554) | 4.64146256 |
| 55 | amino-acid betaine metabolic process (GO:0006577) | 4.59998004 |
| 56 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.59153469 |
| 57 | hormone catabolic process (GO:0042447) | 4.58743310 |
| 58 | triglyceride homeostasis (GO:0070328) | 4.58360861 |
| 59 | acylglycerol homeostasis (GO:0055090) | 4.58360861 |
| 60 | S-adenosylmethionine metabolic process (GO:0046500) | 4.49548193 |
| 61 | negative regulation of cholesterol transport (GO:0032375) | 4.48460865 |
| 62 | negative regulation of sterol transport (GO:0032372) | 4.48460865 |
| 63 | phospholipid efflux (GO:0033700) | 4.48226725 |
| 64 | bile acid and bile salt transport (GO:0015721) | 4.47352597 |
| 65 | coenzyme catabolic process (GO:0009109) | 4.44716476 |
| 66 | indolalkylamine metabolic process (GO:0006586) | 4.44562145 |
| 67 | glycine metabolic process (GO:0006544) | 4.42212796 |
| 68 | alkaloid metabolic process (GO:0009820) | 4.37630503 |
| 69 | cellular glucuronidation (GO:0052695) | 4.36901377 |
| 70 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.36177209 |
| 71 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.36177209 |
| 72 | amine catabolic process (GO:0009310) | 4.35626203 |
| 73 | cellular biogenic amine catabolic process (GO:0042402) | 4.35626203 |
| 74 | negative regulation of wound healing (GO:0061045) | 4.35392911 |
| 75 | imidazole-containing compound metabolic process (GO:0052803) | 4.34558804 |
| 76 | plasma lipoprotein particle clearance (GO:0034381) | 4.30928693 |
| 77 | cellular amino acid catabolic process (GO:0009063) | 4.30389587 |
| 78 | cellular ketone body metabolic process (GO:0046950) | 4.29548919 |
| 79 | negative regulation of coagulation (GO:0050819) | 4.27218154 |
| 80 | glutamate metabolic process (GO:0006536) | 4.24174814 |
| 81 | serine family amino acid metabolic process (GO:0009069) | 4.21239864 |
| 82 | negative regulation of complement activation (GO:0045916) | 4.20453482 |
| 83 | cholesterol efflux (GO:0033344) | 4.17270696 |
| 84 | benzene-containing compound metabolic process (GO:0042537) | 4.16615921 |
| 85 | ethanol oxidation (GO:0006069) | 4.07493181 |
| 86 | arginine metabolic process (GO:0006525) | 4.07206122 |
| 87 | cellular modified amino acid catabolic process (GO:0042219) | 4.05492329 |
| 88 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.05356594 |
| 89 | fibrinolysis (GO:0042730) | 4.03168678 |
| 90 | aldehyde catabolic process (GO:0046185) | 4.01759324 |
| 91 | serine family amino acid biosynthetic process (GO:0009070) | 3.99863956 |
| 92 | positive regulation of blood coagulation (GO:0030194) | 3.98260113 |
| 93 | positive regulation of hemostasis (GO:1900048) | 3.98260113 |
| 94 | low-density lipoprotein particle remodeling (GO:0034374) | 3.95998180 |
| 95 | acute inflammatory response (GO:0002526) | 3.95276748 |
| 96 | plasma lipoprotein particle assembly (GO:0034377) | 3.94354997 |
| 97 | drug catabolic process (GO:0042737) | 3.92038438 |
| 98 | complement activation, classical pathway (GO:0006958) | 3.89709069 |
| 99 | blood coagulation, intrinsic pathway (GO:0007597) | 3.88723947 |
| 100 | glucuronate metabolic process (GO:0019585) | 3.88275961 |
| 101 | uronic acid metabolic process (GO:0006063) | 3.88275961 |
| 102 | complement activation (GO:0006956) | 3.87309341 |
| 103 | cytolysis (GO:0019835) | 3.87188578 |
| 104 | cofactor catabolic process (GO:0051187) | 3.84934016 |
| 105 | protein activation cascade (GO:0072376) | 3.81645699 |
| 106 | regulation of bile acid biosynthetic process (GO:0070857) | 3.80036361 |
| 107 | acetyl-CoA metabolic process (GO:0006084) | 3.74847971 |
| 108 | organic acid catabolic process (GO:0016054) | 3.74763741 |
| 109 | carboxylic acid catabolic process (GO:0046395) | 3.74763741 |
| 110 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.73952904 |
| 111 | positive regulation of lipid catabolic process (GO:0050996) | 3.73870483 |
| 112 | phospholipid homeostasis (GO:0055091) | 3.73761850 |
| 113 | negative regulation of lipase activity (GO:0060192) | 3.72970233 |
| 114 | cholesterol homeostasis (GO:0042632) | 3.72722814 |
| 115 | steroid catabolic process (GO:0006706) | 3.72645500 |
| 116 | ketone body metabolic process (GO:1902224) | 3.71725019 |
| 117 | regulation of acute inflammatory response (GO:0002673) | 3.70980313 |
| 118 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.69810028 |
| 119 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.69810028 |
| 120 | flavonoid metabolic process (GO:0009812) | 3.68902652 |
| 121 | sterol homeostasis (GO:0055092) | 3.66518266 |
| 122 | positive regulation of coagulation (GO:0050820) | 3.65684273 |
| 123 | short-chain fatty acid metabolic process (GO:0046459) | 3.63351135 |
| 124 | epoxygenase P450 pathway (GO:0019373) | 3.62581659 |
| 125 | NAD biosynthetic process (GO:0009435) | 3.57976253 |
| 126 | plasma lipoprotein particle organization (GO:0071827) | 3.57242190 |
| 127 | exogenous drug catabolic process (GO:0042738) | 3.56327069 |
| 128 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.53697674 |
| 129 | heme transport (GO:0015886) | 3.53378339 |
| 130 | xenobiotic metabolic process (GO:0006805) | 3.50269508 |
| 131 | regulation of apoptotic cell clearance (GO:2000425) | 3.46834745 |
| 132 | regulation of lipoprotein particle clearance (GO:0010984) | 3.42972920 |
| 133 | response to mercury ion (GO:0046689) | 3.41490111 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.37367429 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.15635356 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.10515450 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.50865456 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.33769645 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.12000888 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.71730817 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.06315792 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.01147526 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.08832811 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9938530 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.95233922 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.93723045 |
| 14 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.61674798 |
| 15 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.60510792 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.56061636 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 1.45638994 |
| 18 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.39258720 |
| 19 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.36404903 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.22428426 |
| 21 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.18768708 |
| 22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.16774604 |
| 23 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.14280314 |
| 24 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.10841096 |
| 25 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.05767029 |
| 26 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.04688978 |
| 27 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.01875633 |
| 28 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00124618 |
| 29 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.99569232 |
| 30 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.98308256 |
| 31 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.94628013 |
| 32 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.93771127 |
| 33 | * GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.91674712 |
| 34 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.91568186 |
| 35 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.91562708 |
| 36 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.91198825 |
| 37 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.86384841 |
| 38 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.84156022 |
| 39 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.84089330 |
| 40 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.83941584 |
| 41 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.83088543 |
| 42 | NFYA_21822215_ChIP-Seq_K562_Human | 0.81848813 |
| 43 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.79504606 |
| 44 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.79195011 |
| 45 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.78867663 |
| 46 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.78252686 |
| 47 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.77962621 |
| 48 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.77501328 |
| 49 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.77422695 |
| 50 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.75439728 |
| 51 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.74823536 |
| 52 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.74787923 |
| 53 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.73245279 |
| 54 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.72488994 |
| 55 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.71806320 |
| 56 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.71639713 |
| 57 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.71282012 |
| 58 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71241830 |
| 59 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.70910887 |
| 60 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.70615187 |
| 61 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.69990932 |
| 62 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.69990932 |
| 63 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.68666435 |
| 64 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.68657348 |
| 65 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.67862415 |
| 66 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.66115391 |
| 67 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.66083796 |
| 68 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.65573959 |
| 69 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.65290180 |
| 70 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.63548099 |
| 71 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.61815440 |
| 72 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.61598814 |
| 73 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.61508318 |
| 74 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.61007668 |
| 75 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.60409372 |
| 76 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.59890043 |
| 77 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.59820023 |
| 78 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.59663718 |
| 79 | NFYB_21822215_ChIP-Seq_K562_Human | 0.58890758 |
| 80 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.58847760 |
| 81 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.58112817 |
| 82 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.57728270 |
| 83 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.57442727 |
| 84 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.57241069 |
| 85 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.57120511 |
| 86 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.57029718 |
| 87 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.56711813 |
| 88 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.56330155 |
| 89 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.56012138 |
| 90 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.54386913 |
| 91 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.54303423 |
| 92 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53939334 |
| 93 | AR_20517297_ChIP-Seq_VCAP_Human | 0.53552373 |
| 94 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.53356878 |
| 95 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.53294020 |
| 96 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.53150891 |
| 97 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.53096152 |
| 98 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.52027230 |
| 99 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.51546385 |
| 100 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.50795192 |
| 101 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.50685777 |
| 102 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.50659511 |
| 103 | * RBPJ_21746931_ChIP-Seq_IB4_Human | 0.50136981 |
| 104 | CBP_21632823_ChIP-Seq_H3396_Human | 0.49825769 |
| 105 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.48705681 |
| 106 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.48697465 |
| 107 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.48478748 |
| 108 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.48272044 |
| 109 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.47901624 |
| 110 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.47826771 |
| 111 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.47462360 |
| 112 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.47233328 |
| 113 | * RAC3_21632823_ChIP-Seq_H3396_Human | 0.47144569 |
| 114 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.46015620 |
| 115 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46006299 |
| 116 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.45850328 |
| 117 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.44960162 |
| 118 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.43594644 |
| 119 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.43439975 |
| 120 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.43319850 |
| 121 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.42906990 |
| 122 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.42828051 |
| 123 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.42800845 |
| 124 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.42356899 |
| 125 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.41979480 |
| 126 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.40721563 |
| 127 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.40525168 |
| 128 | GATA1_19941826_ChIP-Seq_K562_Human | 0.39613256 |
| 129 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.39545703 |
| 130 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.39226336 |
| 131 | GATA2_19941826_ChIP-Seq_K562_Human | 0.38348396 |
| 132 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.38338770 |
| 133 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.37719380 |
| 134 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.37250932 |
| 135 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.36739626 |
| 136 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.36727474 |
| 137 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.36532500 |
| 138 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.35536358 |
| 139 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.35185948 |
| 140 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.35058975 |
| 141 | NCOR_22424771_ChIP-Seq_293T_Human | 0.34758538 |
| 142 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.34728087 |
| 143 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.34725779 |
| 144 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.34355810 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.27347409 |
| 2 | MP0005360_urolithiasis | 7.59041809 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.57811244 |
| 4 | MP0005365_abnormal_bile_salt | 6.22089782 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.18833253 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.22493374 |
| 7 | MP0003252_abnormal_bile_duct | 3.99199971 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.55401159 |
| 9 | MP0009840_abnormal_foam_cell | 3.17694518 |
| 10 | MP0005083_abnormal_biliary_tract | 3.02987352 |
| 11 | MP0003195_calcinosis | 2.77586630 |
| 12 | MP0005332_abnormal_amino_acid | 2.75304793 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.59950304 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.23393073 |
| 15 | MP0000609_abnormal_liver_physiology | 2.15589228 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.14646668 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.08770526 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.01472522 |
| 19 | MP0003868_abnormal_feces_composition | 2.00586669 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.82912896 |
| 21 | MP0001764_abnormal_homeostasis | 1.70119004 |
| 22 | MP0009697_abnormal_copulation | 1.62653976 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56224507 |
| 24 | MP0003011_delayed_dark_adaptation | 1.40606127 |
| 25 | MP0005451_abnormal_body_composition | 1.36923910 |
| 26 | MP0003186_abnormal_redox_activity | 1.27290237 |
| 27 | MP0003656_abnormal_erythrocyte_physiolo | 1.24502954 |
| 28 | MP0009643_abnormal_urine_homeostasis | 1.22094559 |
| 29 | MP0000598_abnormal_liver_morphology | 1.17753931 |
| 30 | MP0005647_abnormal_sex_gland | 1.14660252 |
| 31 | MP0003705_abnormal_hypodermis_morpholog | 1.11738085 |
| 32 | MP0002132_abnormal_respiratory_system | 1.07836067 |
| 33 | MP0009764_decreased_sensitivity_to | 1.06547796 |
| 34 | MP0002254_reproductive_system_inflammat | 1.04282815 |
| 35 | MP0000604_amyloidosis | 1.02908194 |
| 36 | MP0009763_increased_sensitivity_to | 1.02382889 |
| 37 | MP0005187_abnormal_penis_morphology | 0.96114379 |
| 38 | MP0010368_abnormal_lymphatic_system | 0.93963113 |
| 39 | MP0005636_abnormal_mineral_homeostasis | 0.90358534 |
| 40 | MP0008469_abnormal_protein_level | 0.89386255 |
| 41 | MP0005408_hypopigmentation | 0.88164280 |
| 42 | MP0005670_abnormal_white_adipose | 0.87064885 |
| 43 | MP0001915_intracranial_hemorrhage | 0.86354306 |
| 44 | MP0009642_abnormal_blood_homeostasis | 0.86207138 |
| 45 | MP0005084_abnormal_gallbladder_morpholo | 0.81767702 |
| 46 | MP0005376_homeostasis/metabolism_phenot | 0.80328881 |
| 47 | MP0006036_abnormal_mitochondrial_physio | 0.79403641 |
| 48 | MP0009765_abnormal_xenobiotic_induced | 0.78483868 |
| 49 | MP0002876_abnormal_thyroid_physiology | 0.75660899 |
| 50 | MP0002078_abnormal_glucose_homeostasis | 0.75289005 |
| 51 | MP0005220_abnormal_exocrine_pancreas | 0.74483165 |
| 52 | MP0002971_abnormal_brown_adipose | 0.70291006 |
| 53 | MP0002282_abnormal_trachea_morphology | 0.69678721 |
| 54 | MP0003690_abnormal_glial_cell | 0.69176581 |
| 55 | MP0004130_abnormal_muscle_cell | 0.68930755 |
| 56 | MP0005535_abnormal_body_temperature | 0.67700824 |
| 57 | MP0005334_abnormal_fat_pad | 0.67612659 |
| 58 | MP0001661_extended_life_span | 0.64760172 |
| 59 | MP0005266_abnormal_metabolism | 0.64581383 |
| 60 | MP0009053_abnormal_anal_canal | 0.63746507 |
| 61 | MP0000639_abnormal_adrenal_gland | 0.60069524 |
| 62 | MP0009785_altered_susceptibility_to | 0.59463038 |
| 63 | MP0003329_amyloid_beta_deposits | 0.57894264 |
| 64 | MP0003879_abnormal_hair_cell | 0.56275046 |
| 65 | MP0001756_abnormal_urination | 0.55752704 |
| 66 | MP0006035_abnormal_mitochondrial_morpho | 0.54974088 |
| 67 | MP0002249_abnormal_larynx_morphology | 0.54922316 |
| 68 | MP0005448_abnormal_energy_balance | 0.51982003 |
| 69 | MP0005464_abnormal_platelet_physiology | 0.51254244 |
| 70 | MP0005023_abnormal_wound_healing | 0.49072050 |
| 71 | MP0004381_abnormal_hair_follicle | 0.48938556 |
| 72 | MP0002928_abnormal_bile_duct | 0.48410485 |
| 73 | MP0002822_catalepsy | 0.47843568 |
| 74 | MP0003638_abnormal_response/metabolism_ | 0.46206737 |
| 75 | MP0008873_increased_physiological_sensi | 0.45913754 |
| 76 | MP0008874_decreased_physiological_sensi | 0.45737897 |
| 77 | MP0005395_other_phenotype | 0.45581786 |
| 78 | MP0003724_increased_susceptibility_to | 0.44794823 |
| 79 | MP0003718_maternal_effect | 0.44717405 |
| 80 | MP0002136_abnormal_kidney_physiology | 0.43897104 |
| 81 | MP0003436_decreased_susceptibility_to | 0.42688832 |
| 82 | MP0004782_abnormal_surfactant_physiolog | 0.41685444 |
| 83 | MP0005166_decreased_susceptibility_to | 0.40337406 |
| 84 | MP0000579_abnormal_nail_morphology | 0.40195506 |
| 85 | MP0009384_cardiac_valve_regurgitation | 0.40194608 |
| 86 | MP0003075_altered_response_to | 0.39961186 |
| 87 | MP0002837_dystrophic_cardiac_calcinosis | 0.39739646 |
| 88 | MP0003953_abnormal_hormone_level | 0.38522473 |
| 89 | MP0005248_abnormal_Harderian_gland | 0.38467969 |
| 90 | MP0008872_abnormal_physiological_respon | 0.38151879 |
| 91 | MP0005058_abnormal_lysosome_morphology | 0.37753343 |
| 92 | MP0005666_abnormal_adipose_tissue | 0.36633227 |
| 93 | MP0009672_abnormal_birth_weight | 0.35588965 |
| 94 | MP0002796_impaired_skin_barrier | 0.34633524 |
| 95 | MP0000230_abnormal_systemic_arterial | 0.32712630 |
| 96 | MP0000249_abnormal_blood_vessel | 0.31374951 |
| 97 | MP0002332_abnormal_exercise_endurance | 0.31163710 |
| 98 | MP0009115_abnormal_fat_cell | 0.30808230 |
| 99 | MP0001243_abnormal_dermal_layer | 0.30618112 |
| 100 | MP0004883_abnormal_blood_vessel | 0.30049204 |
| 101 | MP0006082_CNS_inflammation | 0.29712611 |
| 102 | MP0003959_abnormal_lean_body | 0.29055212 |
| 103 | MP0001853_heart_inflammation | 0.28931172 |
| 104 | MP0001881_abnormal_mammary_gland | 0.28313407 |
| 105 | MP0002970_abnormal_white_adipose | 0.28242537 |
| 106 | MP0010386_abnormal_urinary_bladder | 0.28165096 |
| 107 | MP0001845_abnormal_inflammatory_respons | 0.27706613 |
| 108 | MP0002168_other_aberrant_phenotype | 0.27358210 |
| 109 | MP0002090_abnormal_vision | 0.27229980 |
| 110 | MP0000467_abnormal_esophagus_morphology | 0.26902320 |
| 111 | MP0002060_abnormal_skin_morphology | 0.26607847 |
| 112 | MP0005164_abnormal_response_to | 0.25317227 |
| 113 | MP0005397_hematopoietic_system_phenotyp | 0.22969707 |
| 114 | MP0001545_abnormal_hematopoietic_system | 0.22969707 |
| 115 | MP0000427_abnormal_hair_cycle | 0.22334422 |
| 116 | MP0002128_abnormal_blood_circulation | 0.19835917 |
| 117 | MP0005197_abnormal_uvea_morphology | 0.19638735 |
| 118 | MP0001851_eye_inflammation | 0.19375151 |
| 119 | MP0003633_abnormal_nervous_system | 0.19292280 |
| 120 | MP0000566_synostosis | 0.18608650 |
| 121 | MP0000920_abnormal_myelination | 0.18111029 |
| 122 | MP0001986_abnormal_taste_sensitivity | 0.17585033 |
| 123 | MP0004272_abnormal_basement_membrane | 0.15028947 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.48608760 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.46224753 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.42903075 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.79151229 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.67440908 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.46707871 |
| 7 | Xanthomatosis (HP:0000991) | 6.33384157 |
| 8 | Complement deficiency (HP:0004431) | 5.74077288 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.57205301 |
| 10 | Joint hemorrhage (HP:0005261) | 4.80167309 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.79642505 |
| 12 | Epidermoid cyst (HP:0200040) | 4.68620699 |
| 13 | Hyperammonemia (HP:0001987) | 4.61083272 |
| 14 | Abnormality of the common coagulation pathway (HP:0010990) | 4.49442430 |
| 15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.40851162 |
| 16 | Hyperglycinemia (HP:0002154) | 4.36522246 |
| 17 | Abnormality of methionine metabolism (HP:0010901) | 4.36113960 |
| 18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.28263438 |
| 19 | Fat malabsorption (HP:0002630) | 4.21387838 |
| 20 | Ketosis (HP:0001946) | 4.20748799 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.20168203 |
| 22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.18981007 |
| 23 | Abnormality of complement system (HP:0005339) | 4.18873581 |
| 24 | Hypoalphalipoproteinemia (HP:0003233) | 4.15719395 |
| 25 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.95443149 |
| 26 | Hyperglycinuria (HP:0003108) | 3.86041122 |
| 27 | Abnormality of glycine metabolism (HP:0010895) | 3.84631480 |
| 28 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.84631480 |
| 29 | Abnormality of the intrinsic pathway (HP:0010989) | 3.81032079 |
| 30 | Conjugated hyperbilirubinemia (HP:0002908) | 3.78740466 |
| 31 | Hypoglycemic coma (HP:0001325) | 3.77950294 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.63242718 |
| 33 | Hyperbilirubinemia (HP:0002904) | 3.36114939 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.35529663 |
| 35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.28269421 |
| 36 | Steatorrhea (HP:0002570) | 3.19625177 |
| 37 | Abnormality of serum amino acid levels (HP:0003112) | 3.09767067 |
| 38 | Abnormality of nucleobase metabolism (HP:0010932) | 3.06579852 |
| 39 | Delayed CNS myelination (HP:0002188) | 3.05948952 |
| 40 | Hepatocellular carcinoma (HP:0001402) | 3.01378362 |
| 41 | Spontaneous abortion (HP:0005268) | 3.00912751 |
| 42 | Ketoacidosis (HP:0001993) | 2.94787005 |
| 43 | Myocardial infarction (HP:0001658) | 2.93993543 |
| 44 | Hypochromic microcytic anemia (HP:0004840) | 2.93154603 |
| 45 | Osteomalacia (HP:0002749) | 2.89572004 |
| 46 | Skin nodule (HP:0200036) | 2.89395768 |
| 47 | Systemic lupus erythematosus (HP:0002725) | 2.88644206 |
| 48 | Metabolic acidosis (HP:0001942) | 2.71607220 |
| 49 | Reduced antithrombin III activity (HP:0001976) | 2.67886570 |
| 50 | Abnormality of purine metabolism (HP:0004352) | 2.62148204 |
| 51 | Acanthocytosis (HP:0001927) | 2.61992896 |
| 52 | Fair hair (HP:0002286) | 2.61307851 |
| 53 | Lethargy (HP:0001254) | 2.60469091 |
| 54 | Purpura (HP:0000979) | 2.59612681 |
| 55 | Neonatal hypoglycemia (HP:0001998) | 2.58387982 |
| 56 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.55826619 |
| 57 | Glomerulonephritis (HP:0000099) | 2.52927112 |
| 58 | Abnormal gallbladder morphology (HP:0012437) | 2.51834943 |
| 59 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.50568442 |
| 60 | Dicarboxylic aciduria (HP:0003215) | 2.50568442 |
| 61 | Spastic diplegia (HP:0001264) | 2.50548488 |
| 62 | Vascular calcification (HP:0004934) | 2.49414094 |
| 63 | Pulmonary embolism (HP:0002204) | 2.46671337 |
| 64 | Cerebral edema (HP:0002181) | 2.45040788 |
| 65 | Cholelithiasis (HP:0001081) | 2.43960786 |
| 66 | Hypoglycemic seizures (HP:0002173) | 2.43488059 |
| 67 | Gout (HP:0001997) | 2.41537424 |
| 68 | Mitral stenosis (HP:0001718) | 2.40525825 |
| 69 | Neonatal onset (HP:0003623) | 2.40101791 |
| 70 | Abnormal gallbladder physiology (HP:0012438) | 2.38842310 |
| 71 | Cholecystitis (HP:0001082) | 2.38842310 |
| 72 | Irritability (HP:0000737) | 2.37196372 |
| 73 | Amyloidosis (HP:0011034) | 2.28479420 |
| 74 | Cardiovascular calcification (HP:0011915) | 2.20991160 |
| 75 | Gingival bleeding (HP:0000225) | 2.19934076 |
| 76 | Esophageal varix (HP:0002040) | 2.19552378 |
| 77 | Sensorimotor neuropathy (HP:0007141) | 2.13856068 |
| 78 | Malnutrition (HP:0004395) | 2.13510015 |
| 79 | Pancreatitis (HP:0001733) | 2.12719851 |
| 80 | Menorrhagia (HP:0000132) | 2.12574641 |
| 81 | Elevated alkaline phosphatase (HP:0003155) | 2.10317006 |
| 82 | Enlarged kidneys (HP:0000105) | 2.10095301 |
| 83 | Brushfield spots (HP:0001088) | 2.09282096 |
| 84 | Hyperphosphaturia (HP:0003109) | 2.06648319 |
| 85 | Thrombophlebitis (HP:0004418) | 2.06283602 |
| 86 | Increased serum ferritin (HP:0003281) | 2.04496520 |
| 87 | Abnormality of the gallbladder (HP:0005264) | 2.04493924 |
| 88 | Late onset (HP:0003584) | 2.03927842 |
| 89 | Vomiting (HP:0002013) | 2.02768718 |
| 90 | Poikilocytosis (HP:0004447) | 1.99772622 |
| 91 | Generalized aminoaciduria (HP:0002909) | 1.98702007 |
| 92 | Opisthotonus (HP:0002179) | 1.98252280 |
| 93 | Joint swelling (HP:0001386) | 1.97759938 |
| 94 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.97052344 |
| 95 | Abnormality of iron homeostasis (HP:0011031) | 1.92524087 |
| 96 | Hemorrhage of the eye (HP:0011885) | 1.91968741 |
| 97 | Rickets (HP:0002748) | 1.91921750 |
| 98 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.91685381 |
| 99 | Gangrene (HP:0100758) | 1.90883064 |
| 100 | Arthropathy (HP:0003040) | 1.89381565 |
| 101 | Abnormal cartilage morphology (HP:0002763) | 1.88778195 |
| 102 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.88483970 |
| 103 | Renal cortical cysts (HP:0000803) | 1.86583904 |
| 104 | Abnormality of urine glucose concentration (HP:0011016) | 1.86189918 |
| 105 | Glycosuria (HP:0003076) | 1.86189918 |
| 106 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.83918301 |
| 107 | Alkalosis (HP:0001948) | 1.83680791 |
| 108 | Generalized hypopigmentation of hair (HP:0011358) | 1.83466889 |
| 109 | Abnormality of the Achilles tendon (HP:0005109) | 1.82044335 |
| 110 | Elevated hepatic transaminases (HP:0002910) | 1.81040845 |
| 111 | Epistaxis (HP:0000421) | 1.80534449 |
| 112 | Hypophosphatemic rickets (HP:0004912) | 1.80229894 |
| 113 | Abnormality of proline metabolism (HP:0010907) | 1.79927966 |
| 114 | Hydroxyprolinuria (HP:0003080) | 1.79927966 |
| 115 | Status epilepticus (HP:0002133) | 1.79456318 |
| 116 | Nephritis (HP:0000123) | 1.77819161 |
| 117 | Abnormality of vitamin metabolism (HP:0100508) | 1.76767319 |
| 118 | Atrioventricular block (HP:0001678) | 1.75372873 |
| 119 | Hyperglycemia (HP:0003074) | 1.74057326 |
| 120 | Abnormal delivery (HP:0001787) | 1.72522590 |
| 121 | Abnormal biliary tract physiology (HP:0012439) | 1.70936375 |
| 122 | Bile duct proliferation (HP:0001408) | 1.70936375 |
| 123 | Cerebral palsy (HP:0100021) | 1.69745138 |
| 124 | Abnormal urine phosphate concentration (HP:0012599) | 1.66483806 |
| 125 | Blue irides (HP:0000635) | 1.58136493 |
| 126 | Increased mean platelet volume (HP:0011877) | 1.47986307 |
| 127 | Potter facies (HP:0002009) | 1.45015125 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.98811974 |
| 2 | FGFR4 | 4.50358303 |
| 3 | SIK1 | 4.39359079 |
| 4 | ERN1 | 4.18810343 |
| 5 | ERBB4 | 3.28863634 |
| 6 | INSRR | 3.11213057 |
| 7 | TAOK3 | 3.10001036 |
| 8 | MAP2K4 | 2.38019719 |
| 9 | MST1R | 2.19090305 |
| 10 | PKN2 | 2.17244768 |
| 11 | PRPF4B | 2.06733472 |
| 12 | MAPK11 | 2.02529102 |
| 13 | FLT3 | 1.89722836 |
| 14 | LATS1 | 1.73545878 |
| 15 | TYK2 | 1.70646017 |
| 16 | PIK3CG | 1.69326824 |
| 17 | ABL2 | 1.56261565 |
| 18 | TRIB3 | 1.54559721 |
| 19 | DAPK2 | 1.49976076 |
| 20 | FRK | 1.47486642 |
| 21 | NEK9 | 1.46892184 |
| 22 | PTK6 | 1.46613130 |
| 23 | FGFR2 | 1.46215133 |
| 24 | TNK2 | 1.32626901 |
| 25 | KDR | 1.30737374 |
| 26 | JAK2 | 1.28823511 |
| 27 | MAP3K7 | 1.25995199 |
| 28 | BLK | 1.21467816 |
| 29 | NTRK3 | 1.20655630 |
| 30 | CAMKK2 | 1.20246182 |
| 31 | NLK | 1.18323401 |
| 32 | PRKAA2 | 1.16191782 |
| 33 | ERBB2 | 1.13334446 |
| 34 | MAP3K14 | 1.11742808 |
| 35 | PRKG1 | 1.11041770 |
| 36 | ARAF | 1.10685414 |
| 37 | PINK1 | 1.08153370 |
| 38 | MAP3K10 | 1.07675917 |
| 39 | PDK2 | 1.06707896 |
| 40 | GRK6 | 1.06570028 |
| 41 | TBK1 | 1.04582937 |
| 42 | MAPK4 | 1.03528687 |
| 43 | JAK1 | 1.03499824 |
| 44 | FER | 1.02418288 |
| 45 | MAP2K3 | 1.00165106 |
| 46 | PRKACA | 0.96768352 |
| 47 | PRKCZ | 0.95388641 |
| 48 | MAP3K1 | 0.95304155 |
| 49 | MYLK | 0.95180593 |
| 50 | MAPK15 | 0.94988207 |
| 51 | CAMKK1 | 0.91997170 |
| 52 | MUSK | 0.90374698 |
| 53 | SCYL2 | 0.88912974 |
| 54 | MET | 0.86510437 |
| 55 | MAP3K3 | 0.84533869 |
| 56 | STK38L | 0.84189760 |
| 57 | ZAP70 | 0.83199375 |
| 58 | MAPK12 | 0.83060045 |
| 59 | EPHB1 | 0.80887248 |
| 60 | EPHA3 | 0.80339489 |
| 61 | CDK6 | 0.79999594 |
| 62 | CAMK2G | 0.78577938 |
| 63 | PRKACG | 0.78362378 |
| 64 | CSNK1D | 0.74795177 |
| 65 | TIE1 | 0.73721082 |
| 66 | CSK | 0.71189743 |
| 67 | MAP3K2 | 0.70487415 |
| 68 | GSK3A | 0.69347564 |
| 69 | WNK3 | 0.67270444 |
| 70 | CAMK1D | 0.67032120 |
| 71 | PRKACB | 0.66611531 |
| 72 | PRKCB | 0.66231832 |
| 73 | MAP2K6 | 0.66020298 |
| 74 | PRKAA1 | 0.65286936 |
| 75 | MAP3K11 | 0.65196336 |
| 76 | TGFBR2 | 0.65035150 |
| 77 | DYRK1B | 0.63136635 |
| 78 | IRAK3 | 0.62920176 |
| 79 | RPS6KA3 | 0.62881008 |
| 80 | SGK3 | 0.62854878 |
| 81 | FGFR3 | 0.62807742 |
| 82 | MAPK7 | 0.61353151 |
| 83 | RIPK1 | 0.59221117 |
| 84 | CSF1R | 0.57774414 |
| 85 | PKN1 | 0.57496544 |
| 86 | CSNK1E | 0.56160639 |
| 87 | IKBKE | 0.54642967 |
| 88 | PRKCQ | 0.53962514 |
| 89 | SGK1 | 0.53468534 |
| 90 | CSNK1G1 | 0.52519285 |
| 91 | GRK1 | 0.52254331 |
| 92 | PTK2 | 0.51971088 |
| 93 | BRSK2 | 0.50706207 |
| 94 | MAP3K13 | 0.49619548 |
| 95 | PDPK1 | 0.49432091 |
| 96 | IGF1R | 0.48684654 |
| 97 | SRC | 0.48489247 |
| 98 | SGK2 | 0.47576232 |
| 99 | CSNK2A1 | 0.47337436 |
| 100 | EPHA4 | 0.46411475 |
| 101 | MAP2K1 | 0.45708722 |
| 102 | MAP3K12 | 0.45048487 |
| 103 | CSNK2A2 | 0.43906539 |
| 104 | PRKCG | 0.42837178 |
| 105 | MAP3K5 | 0.42244950 |
| 106 | RET | 0.41250524 |
| 107 | PBK | 0.40343498 |
| 108 | KSR2 | 0.39432793 |
| 109 | AKT2 | 0.39409832 |
| 110 | TAOK2 | 0.39223427 |
| 111 | EGFR | 0.38219824 |
| 112 | CDK4 | 0.37591942 |
| 113 | MAP3K6 | 0.36399306 |
| 114 | MAPK3 | 0.35200108 |
| 115 | STK16 | 0.34247586 |
| 116 | CSNK1G2 | 0.33504848 |
| 117 | KIT | 0.33446097 |
| 118 | ICK | 0.32951656 |
| 119 | SGK223 | 0.32459224 |
| 120 | SGK494 | 0.32459224 |
| 121 | MTOR | 0.31431757 |
| 122 | PDK1 | 0.31421872 |
| 123 | CSNK1G3 | 0.30106048 |
| 124 | CAMK4 | 0.29502817 |
| 125 | IRAK2 | 0.29218414 |
| 126 | IRAK1 | 0.28244772 |
| 127 | PRKCA | 0.27706192 |
| 128 | PIK3CA | 0.26880651 |
| 129 | AKT3 | 0.25537926 |
| 130 | ABL1 | 0.25262074 |
| 131 | LATS2 | 0.24691919 |
| 132 | PDK3 | 0.23971706 |
| 133 | PDK4 | 0.23971706 |
| 134 | MAP2K2 | 0.22132564 |
| 135 | CSNK1A1L | 0.21733002 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.63919043 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.65618860 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.48569464 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.34941757 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.11713868 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.82370166 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.70561513 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.60155514 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.56687035 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.54093238 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.43790006 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.34014307 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.24592908 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.15436242 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.09052337 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.07490555 |
| 17 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.97024750 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.96494795 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.94584849 |
| 20 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.90439754 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.88475844 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.88065105 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.84695548 |
| 24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.78719836 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.76777679 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.75907346 |
| 27 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.74680886 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.72126987 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.68394547 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.67707554 |
| 31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.58926719 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.57999173 |
| 33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.49588052 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.49450603 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.49240043 |
| 36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.49061493 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.44175200 |
| 38 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.33542741 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.33133611 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.32817660 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.30289747 |
| 42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.29518128 |
| 43 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.20739667 |
| 44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.20667901 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 1.19801436 |
| 46 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.18943750 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.13401949 |
| 48 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.11249927 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.10650895 |
| 50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.99517397 |
| 51 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.96544674 |
| 52 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.94969030 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94389398 |
| 54 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.92941901 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.90082449 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88860511 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.83529298 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.81306723 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.78675258 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.73104493 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68438896 |
| 62 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.66576343 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64218469 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56420451 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52184345 |
| 66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.46242747 |
| 67 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45419725 |
| 68 | Prion diseases_Homo sapiens_hsa05020 | 0.43460143 |
| 69 | Pertussis_Homo sapiens_hsa05133 | 0.41300132 |
| 70 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.38263287 |
| 71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.23810840 |
| 72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.22881231 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22763789 |
| 74 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.22139701 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.22074507 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21520792 |
| 77 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.18065832 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15277618 |
| 79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.09756155 |
| 80 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.01377581 |
| 81 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01141147 |
| 82 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.2549258 |
| 83 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2520883 |
| 84 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2491153 |
| 85 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.2443018 |
| 86 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2442528 |
| 87 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2285365 |
| 88 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.2260130 |
| 89 | Amoebiasis_Homo sapiens_hsa05146 | -0.2149608 |
| 90 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2087353 |
| 91 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2033034 |
| 92 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2015101 |
| 93 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1994013 |
| 94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1937739 |
| 95 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1930380 |
| 96 | Hepatitis C_Homo sapiens_hsa05160 | -0.1819822 |
| 97 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1631692 |
| 98 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1612281 |
| 99 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1513493 |
| 100 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1456869 |
| 101 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1334725 |
| 102 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1153642 |
| 103 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1111935 |
| 104 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0975988 |
| 105 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0781696 |
| 106 | Mineral absorption_Homo sapiens_hsa04978 | -0.0746702 |
| 107 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0597131 |
| 108 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0551447 |
| 109 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0270301 |

